283 related articles for article (PubMed ID: 9171095)
1. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site.
Galien R; Garcia T
Nucleic Acids Res; 1997 Jun; 25(12):2424-9. PubMed ID: 9171095
[TBL] [Abstract][Full Text] [Related]
2. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
Galien R; Evans HF; Garcia T
Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
[TBL] [Abstract][Full Text] [Related]
3. The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.
Merola M; Blanchard B; Tovey MG
J Interferon Cytokine Res; 1996 Oct; 16(10):783-98. PubMed ID: 8910763
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mechanisms of interleukin-6 gene repression by estrogen receptor.
Kurebayashi S; Miyashita Y; Hirose T; Kasayama S; Akira S; Kishimoto T
J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):11-7. PubMed ID: 9182853
[TBL] [Abstract][Full Text] [Related]
5. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B.
Stein B; Baldwin AS
Mol Cell Biol; 1993 Nov; 13(11):7191-8. PubMed ID: 8413306
[TBL] [Abstract][Full Text] [Related]
6. Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter.
Catron KM; Brickwood JR; Shang C; Li Y; Shannon MF; Parks TP
Cell Growth Differ; 1998 Nov; 9(11):949-59. PubMed ID: 9831247
[TBL] [Abstract][Full Text] [Related]
7. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta.
Stein B; Yang MX
Mol Cell Biol; 1995 Sep; 15(9):4971-9. PubMed ID: 7651415
[TBL] [Abstract][Full Text] [Related]
8. A NF-kappaB p65 subunit is indispensable for activating manganese superoxide: dismutase gene transcription mediated by tumor necrosis factor-alpha.
Maehara K; Hasegawa T; Isobe KI
J Cell Biochem; 2000 Apr; 77(3):474-86. PubMed ID: 10760955
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50.
Agrawal A; Cha-Molstad H; Samols D; Kushner I
J Immunol; 2001 Feb; 166(4):2378-84. PubMed ID: 11160296
[TBL] [Abstract][Full Text] [Related]
10. Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.
Ruocco MR; Chen X; Ambrosino C; Dragonetti E; Liu W; Mallardo M; De Falco G; Palmieri C; Franzoso G; Quinto I; Venuta S; Scala G
J Biol Chem; 1996 Sep; 271(37):22479-86. PubMed ID: 8798413
[TBL] [Abstract][Full Text] [Related]
11. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta.
Karlsen JR; Borregaard N; Cowland JB
J Biol Chem; 2010 May; 285(19):14088-100. PubMed ID: 20220144
[TBL] [Abstract][Full Text] [Related]
12. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6.
Yan SF; Tritto I; Pinsky D; Liao H; Huang J; Fuller G; Brett J; May L; Stern D
J Biol Chem; 1995 May; 270(19):11463-71. PubMed ID: 7744784
[TBL] [Abstract][Full Text] [Related]
13. Cooperative effects of C/EBP-like and NF kappa B-like binding sites on rat serum amyloid A1 gene expression in liver cells.
Li X; Liao WS
Nucleic Acids Res; 1992 Sep; 20(18):4765-72. PubMed ID: 1408789
[TBL] [Abstract][Full Text] [Related]
14. 17beta-estradiol inhibits the production of RANTES in human keratinocytes.
Kanda N; Watanabe S
J Invest Dermatol; 2003 Mar; 120(3):420-7. PubMed ID: 12603855
[TBL] [Abstract][Full Text] [Related]
15. CCAAT box enhancer binding protein alpha (C/EBP-alpha) stimulates kappaB element-mediated transcription in transfected cells.
Vietor I; Oliveira IC; Vilcek J
J Biol Chem; 1996 Mar; 271(10):5595-602. PubMed ID: 8621420
[TBL] [Abstract][Full Text] [Related]
16. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
17. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor.
Ray P; Ghosh SK; Zhang DH; Ray A
FEBS Lett; 1997 Jun; 409(1):79-85. PubMed ID: 9199508
[TBL] [Abstract][Full Text] [Related]
18. The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1.
Hu HM; Tian Q; Baer M; Spooner CJ; Williams SC; Johnson PF; Schwartz RC
J Biol Chem; 2000 May; 275(21):16373-81. PubMed ID: 10748205
[TBL] [Abstract][Full Text] [Related]
19. Binding of C/EBP and RBP (CBF1) to overlapping sites regulates interleukin-6 gene expression.
Vales LD; Friedl EM
J Biol Chem; 2002 Nov; 277(45):42438-46. PubMed ID: 12200447
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line.
Faggioli L; Costanzo C; Merola M; Bianchini E; Furia A; Carsana A; Palmieri M
Eur J Biochem; 1996 Aug; 239(3):624-31. PubMed ID: 8774705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
